What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Search narrowed by
national product information on condition that the national product information will be submitted to BASG 4 months prior to the planned market launch of the medicinal product at the latest. Conditional a [...] the texts (see market launch). Market launch: The national product information must be submitted to BASG 4 months prior to the planned market launch. Submission of the texts with no open procedures: via [...] information as well. Finally the MAH will receive an approval letter (Genehmigungsschreiben) from BASG referring to the already issued conditional authorisation including the national product information
medical device or in vitro diagnostic medical device. The Federal Office for Safety in Health Care (BASG) performs delimitation or classifications of medical devices or in vitro diagnostic devices based [...] Electronic Submission Regulation 2011, the notification has to be done by email to medizinprodukte@basg.gv.at . The European accredited reporting forms are to be used for reporting. For field safety corrective [...] are met. Please note the current Fee Regulation . To apply for a derogation, contact medizinprodukte@basg.gv.at in advance by e-mail.
Care (BASG) as well as the manufacturer and, where applicable, the manufacturer’s authorised representative and the importer. Contact with the BASG should be made by e-mail to medizinprodukte@basg.gv.at [...] Health Care (BASG) must be informed at least 28 days before a relabelled or repackaged product is made available on the market. Please contact the BASG via e-mail to medizinprodukte@basg.gv.at .
Off-Label Use The BASG, the ÖGARI and the Austrian Patient Ombudsman have agreed on the following wording on the subject of off-label use. “Off-label use" refers to the use of a drug in the context of
exceeding the limits to trade (wholesale trade in medicinal products)." From the point of view of the BASG, the borderline to a trade is crossed if deliveries are made regularly or with the intention of generating
the following link: https://medprodabgabe.basg.gv.at The self-declaration must be submitted in electronic form via the web form (link: https://medprodabgabe.basg.gv.at) . You will receive an RsB letter from [...] device - they fall neither under the Medical Devices Levy Ordinance nor under the jurisdiction of the BASG. General Independent of the registration in the medical device register, every natural or legal person [...] medical device levy has changed as of 1/1/2019: Click on the following URL: https://medprodabgabe.basg.gv.at Enter your identifier and password. You received your ID and password with the information letter
information and, if necessary, submit a formal report to the BASG. If you still wish to contact BASG, please send an informal email to medizinprodukte@basg.gv.at . Your notification should include the information [...] root cause analysis. BASG itself does not conduct product investigations. Am I entitled to compensation or a replacement product? The BASG is not responsible for this question. BASG refers to consumer [...] relation to the benefits. What are the activities of the BASG in the field of medical devices? The Federal Office for Safety in Health Care (BASG) is the Austrian authority responsible for overseeing the
Medicinal Product Index Pharmaceutical companies Register of retailers Internet pharmacies BASG official announcement BASG voting results Reporting Human adverse reaction notification Veterinary Adverse Event [...] monographs for comments Archive of monographs Archive of deleted monographs CHMP Meeting Highlights-BASG The CHMP introduces itself For Companies Online services Login online services Reporting adverse reactions [...] (PSURs) FAQ pharmacovigilance Guideline pharmacovigilance Medicinal products Scientific advice by BASG Quality of medicines Medicines for children Plasma derived products Batch release Recombinant proteins
current supply situation of certain radiopharmaceuticals, the Federal Office for Safety in Health Care (BASG)/AGES PharmMed draws attention to particularities in the use of unauthorised medicinal products,
für Amtsärzte Zum Gebrauch für die Organe der Bezirksverwaltungsbehörde - Zur Verfügung gestellt von BASG / AGES OMCL Probenziehung gem. §70 ABO, BGBl. II Nr. 65/2005 (jeweils i.d.g.F.) Formular: Probenb